Sara Khor

ORCID: 0000-0003-0157-528X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Economic and Financial Impacts of Cancer
  • Global Cancer Incidence and Screening
  • Diverticular Disease and Complications
  • Spine and Intervertebral Disc Pathology
  • Cardiac, Anesthesia and Surgical Outcomes
  • Gastrointestinal disorders and treatments
  • Global Health Care Issues
  • Healthcare cost, quality, practices
  • Colorectal Cancer Screening and Detection
  • Pancreatic and Hepatic Oncology Research
  • Anorectal Disease Treatments and Outcomes
  • Aortic aneurysm repair treatments
  • Musculoskeletal pain and rehabilitation
  • Enhanced Recovery After Surgery
  • Aortic Disease and Treatment Approaches
  • Mobile Health and mHealth Applications
  • Cardiac and Coronary Surgery Techniques
  • Blood Pressure and Hypertension Studies
  • Medical Imaging and Analysis
  • Lung Cancer Research Studies
  • Health, Environment, Cognitive Aging
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Multiple and Secondary Primary Cancers
  • Hip and Femur Fractures

Royal Prince Alfred Hospital
2025

Stanford Health Care
2025

Stanford University
2025

University of Washington
2014-2024

Seattle University
2015-2022

St. Mary's Medical Center
2021

St. Mary's Hospital
2021

St Mary's Hospital
2021

National Bureau of Economic Research
2021

New York University
2020

IMPORTANCEFunctional impairment and pain are common indications for the initiation of lumbar spine surgery, but information about expected improvement in these patient-reported outcome (PRO) domains is not readily available to most patients clinicians considering this type surgery. OBJECTIVETo assess population-level PRO response after develop/validate a prediction tool improvement. DESIGN, SETTING, AND PARTICIPANTSThis statewide multicenter cohort was based at 15 Washington state hospitals...

10.1001/jamasurg.2018.0072 article EN JAMA Surgery 2018-03-07

Importance Including race and ethnicity as a predictor in clinical risk prediction algorithms has received increased scrutiny, but there continues to be lack of empirical studies addressing whether simply omitting from the will ultimately affect decision-making for patients minoritized racial ethnic groups. Objective To examine including colorectal cancer recurrence algorithm is associated with bias, defined differences model accuracy that could potentially lead unequal treatment. Design,...

10.1001/jamanetworkopen.2023.18495 article EN cc-by-nc-nd JAMA Network Open 2023-06-15

The poor in low and middle income countries have limited access to health services due purchasing power, residence underserved areas, inadequate literacy. This produces significant gaps care delivery among a population that has disproportionately large burden of disease. They frequently use the private sector, perceived or actual public services. A subset organizations, some called social enterprises, developed novel approaches increase availability, affordability quality through innovative...

10.1186/1478-4505-8-24 article EN cc-by Health Research Policy and Systems 2010-07-15

PURPOSE Although financial toxicity is a growing cancer survivorship issue, no studies have used credit data to estimate the relative risk of hardship in patients with versus individuals without cancer. We conducted population-based retrospective matched cohort study using reports investigate impact diagnosis on adverse events (AFEs). METHODS Western Washington SEER registry (cases) and voter (controls) records from 2013 2018 were linked quarterly TransUnion. Controls age-, sex-, zip...

10.1200/jco.21.01636 article EN Journal of Clinical Oncology 2022-01-07

Abstract Background Current treatment of diffuse-large-B-cell lymphoma (DLBCL) includes rituximab, an expensive drug, combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy. Economic models have predicted rituximab plus CHOP (RCHOP) to be a cost-effective alternative alone as first-line DLBCL, but it remains unclear what its real-world costs cost-effectiveness are in routine clinical practice. Methods We performed population-based retrospective cohort...

10.1186/1471-2407-14-586 article EN cc-by BMC Cancer 2014-08-12

Abstract Background The goal of cytoreductive surgery for peritoneal malignancy is to remove all macroscopic disease, which occasionally requires the excision umbilicus. While absence umbilicus can be aesthetically undesirable patients, umbilical reconstruction rarely performed due perceived complexity and increased risk wound infections (Sakata et al. in Colorectal Dis 23:1153–1157, 2021). This study aims evaluate outcomes, cosmetic results patient satisfaction during surgery. Methods...

10.1007/s10151-024-03095-y article EN cc-by Techniques in Coloproctology 2025-01-21

Abstract Background Breast cancer screening (BCS) inequities are evident at national and local levels, many health systems want to address these inequities, but may lack data about contributing factors. The objective of this study was inform system interventions through an exploratory analysis potential multilevel contributors BCS using data. Methods authors conducted a cross‐sectional within large academic including 19,774 individuals who identified as Black ( n = 1445) or White 18,329)...

10.1002/cncr.35734 article EN Cancer 2025-01-25

Summary We conducted a multi‐institutional population‐based analysis of the survival and toxicity associated with addition rituximab to chemotherapy for patients diffuse large B‐cell lymphoma ( DLBCL ), including aged ≥80 years, who were excluded from published randomized trials. Using registries in Ontario, we identified 4021 received or without (R‐ CHOP [rituximab cyclophosphamide, doxorubicin, vincristine prednisone] ) between 1996 2007, 397 years. After propensity score matching, overall...

10.1111/j.1365-2141.2012.09177.x article EN British Journal of Haematology 2012-06-05

Machine learning is used to analyze big data, often for the purposes of prediction. Analyzing a patient's healthcare utilization pattern may provide more precise estimates risk adverse events (AE) or death. We sought characterize prior surgery using machine prediction.Patients from MarketScan Commercial Claims and Encounters Database undergoing elective 2007-2012 with ≥1 comorbidity were included. All available claims occurring within six months assessed. More than 300 predictors defined by...

10.13063/2327-9214.1278 article EN eGEMs (Generating Evidence & Methods to improve patient outcomes) 2017-04-20

Background: Surgical site infection (SSI) after spine surgery is classified as a "never event" by the Centers for Medicare and Medicaid. Intra-wound antibiotics (IWA) have been proposed to reduce incidence of SSI, but robust evidence support its use lacking. Methods: Prospective cohort undergoing fusion at 20 Washington State hospitals (July 2011 March 2014) participating in Spine Care Outcomes Assessment Program (Spine SCOAP) linked discharge tracking system. Patient, hospital, operative...

10.1089/sur.2015.146 article EN Surgical Infections 2016-02-02

BackgroundIn response to the COVID-19 pandemic, two new temporary hospitals were constructed in record time Wuhan, China, help combat fast-spreading virus February 2020.Using experience of one hospital as a case study, we discuss health and economic implications this strategy its potential application other countries. MethodsThis retrospective observational study analyzed resource utilization clinical outcomes data for 2011 inpatients diagnosed with admitted Leishenshan Hospital during 67...

10.7189/jogh.11.05023 article EN cc-by Journal of Global Health 2021-12-04

Statewide retrospective cohort study using prospectively collected data from the Spine Care and Outcomes Assessment Program, capturing ∼75% of state's spine fusion procedures.The aim this was to estimate variation in patient-reported outcomes (PROs) 1 year after elective lumbar surgery across surgeons hospitals; discuss potential impact guiding patient selection a PRO prediction tool.Despite an increasing interest incorporating PROs as part move toward value-based payment improve quality,...

10.1097/brs.0000000000003299 article EN Spine 2019-12-06

PURPOSE There is growing interest in using computable phenotypes or proxies to identify important clinical outcomes, such as cancer recurrence, rich electronic health records data. However, the race/ethnicity-specific accuracies of these remain unclear. We examined whether accuracy a proxy for colorectal (CRC) recurrence differed by race/ethnicity and possible mechanisms that drove differences. METHODS Using data from large integrated care system, we identified stratified random sample 282...

10.1200/cci.23.00004 article EN JCO Clinical Cancer Informatics 2023-06-01

Using machine learning to leverage CEA biomarker change and predict colorectal cancer recurrence.

10.1200/cci.23.00066 article EN JCO Clinical Cancer Informatics 2023-09-01

The aim of this study was to evaluate the concordance in grade assignment for gastroenteropancreatic neuroendocrine tumors using mitotic count (MC), Ki-67 proliferative index (KPI), and phosphohistone H3 (PHH3C).Resected were graded based on MC, KPI, PHH3C. Concordance determined a weighted κ statistic. Median survival across each category Kaplan-Meier methods.Of 110 patients, majority had gastrointestinal primaries 1 or 2 tumors. Rates discordance 29% cases KPI versus MC (κW = 0.26), 32%...

10.1097/mpa.0000000000000923 article EN Pancreas 2017-10-17

Objectives: To identify factors associated with the minimum necessary information to determine an individual's eligibility for lung cancer screening (ie, sufficient risk factor documentation) and characterize clinic-level variability in documentation. Study Design: Cross-sectional observational study using electronic health record data from academic system 2019. Methods: We calculated relative of documentation by patient-, provider-, system-level variables Poisson regression models,...

10.37765/ajmc.2023.89354 article EN The American Journal of Managed Care 2023-05-01
Coming Soon ...